Page last updated: 2024-11-05

triclosan and Leishmaniasis, Cutaneous

triclosan has been researched along with Leishmaniasis, Cutaneous in 1 studies

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mesquita, JT1
Romanelli, MM1
de Melo Trinconi Trinconi Cm, C1
Guerra, JM1
Taniwaki, NN1
Uliana, SRB1
Reimão, JQ1
Tempone, AG1

Other Studies

1 other study available for triclosan and Leishmaniasis, Cutaneous

ArticleYear
Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis model.
    Drug development research, 2022, Volume: 83, Issue:2

    Topics: Animals; Antiprotozoal Agents; Drug Repositioning; Humans; Leishmania; Leishmaniasis, Cutaneous; Mic

2022